Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 363

1.

Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.

Ogata T, Shibamura H, Tromp G, Sinha M, Goddard KA, Sakalihasan N, Limet R, MacKean GL, Arthur C, Sueda T, Land S, Kuivaniemi H.

J Vasc Surg. 2005 Jun;41(6):1036-42.

2.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.

Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

3.

Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms.

Wang X, Tromp G, Cole CW, Verloes A, Sakalihasan N, Yoon S, Kuivaniemi H.

Matrix Biol. 1999 Apr;18(2):121-4.

4.

Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.

Elmore JR, Keister BF, Franklin DP, Youkey JR, Carey DJ.

Ann Vasc Surg. 1998 May;12(3):221-8.

PMID:
9588507
5.

The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a systematic review and meta-analysis.

Morris DR, Biros E, Cronin O, Kuivaniemi H, Golledge J.

Heart. 2014 Feb;100(4):295-302. doi: 10.1136/heartjnl-2013-304129. Epub 2013 Jun 27. Review.

PMID:
23813847
6.

Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.

Wieczorek E, Reszka E, Jablonowski Z, Jablonska E, Krol MB, Grzegorczyk A, Gromadzinska J, Sosnowski M, Wasowicz W.

BJU Int. 2013 Dec;112(8):1207-14. doi: 10.1111/bju.12230. Epub 2013 Jul 2.

7.

The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.

Piechota-Polanczyk A, Demyanets S, Mittlboeck M, Hofmann M, Domenig CM, Neumayer C, Wojta J, Klinger M, Nanobachvili J, Huk I.

Eur J Vasc Endovasc Surg. 2015 May;49(5):549-55. doi: 10.1016/j.ejvs.2015.02.011. Epub 2015 Mar 21.

8.

Gene polymorphism -418 G/C of tissue inhibitor of metalloproteinases 2 is associated with abdominal aortic aneurysm.

Mikołajczyk-Stecyna J, Korcz A, Gabriel M, Pawlaczyk K, Oszkinis G, Słomski R.

J Vasc Surg. 2015 May;61(5):1114-9. doi: 10.1016/j.jvs.2013.12.045. Epub 2014 Feb 15.

9.

Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion.

Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R.

J Vasc Surg. 2004 Nov;40(5):995-1000.

10.

Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.

Soini Y, Satta J, Määttä M, Autio-Harmainen H.

J Pathol. 2001 Jun;194(2):225-31.

PMID:
11400152
11.

Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm.

Hinterseher I, Krex D, Kuhlisch E, Schmidt KG, Pilarsky C, Schneiders W, Saeger HD, Bergert H.

World J Surg. 2007 Nov;31(11):2248-54.

PMID:
17899257
12.

Polymorphisms of genes involved in the hypoxia signaling pathway and the development of abdominal aortic aneurysms or large-artery atherosclerosis.

Strauss E, Waliszewski K, Oszkinis G, Staniszewski R.

J Vasc Surg. 2015 May;61(5):1105-13.e3. doi: 10.1016/j.jvs.2014.02.007. Epub 2014 Mar 20.

13.

TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.

Ashworth Briggs EL, Toh T, Eri R, Hewitt AW, Cook AL.

Mol Vis. 2015 Oct 13;21:1162-72. eCollection 2015.

14.

Association of rs1466535 LRP1 but not rs3019885 SLC30A8 and rs6674171 TDRD10 gene polymorphisms with abdominal aortic aneurysm in Italian patients.

Galora S, Saracini C, Pratesi G, Sticchi E, Pulli R, Pratesi C, Abbate R, Giusti B.

J Vasc Surg. 2015 Mar;61(3):787-92. doi: 10.1016/j.jvs.2013.10.090. Epub 2014 Jan 11.

15.

Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma.

Markiewicz L, Majsterek I, Przybylowska K, Dziki L, Waszczyk M, Gacek M, Kaminska A, Szaflik J, Szaflik JP.

Acta Ophthalmol. 2013 Nov;91(7):e516-23. doi: 10.1111/aos.12149. Epub 2013 Jun 25.

16.

Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.

Pietruszewska W, Bojanowska-Poźniak K, Kobos J.

Otolaryngol Pol. 2016 Jun 30;70(3):32-43. doi: 10.5604/00306657.1202546.

PMID:
27386931
17.

Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm.

Hinterseher I, Bergert H, Kuhlisch E, Bloomenthal A, Pilarsky Ch, Ockert D, Schellong S, Saeger HD, Krex D.

J Surg Res. 2006 Jun 15;133(2):121-8. Epub 2006 Feb 3.

PMID:
16458924
18.

Genetic susceptibility to periapical disease: conditional contribution of MMP2 and MMP3 genes to the development of periapical lesions and healing response.

Menezes-Silva R, Khaliq S, Deeley K, Letra A, Vieira AR.

J Endod. 2012 May;38(5):604-7. doi: 10.1016/j.joen.2012.02.009. Epub 2012 Mar 24.

19.

Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.

van Diemen CC, Postma DS, Siedlinski M, Blokstra A, Smit HA, Boezen HM.

Respir Res. 2011 Apr 27;12:57. doi: 10.1186/1465-9921-12-57.

20.

Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.

Nishimura K, Ikebuchi M, Kanaoka Y, Ohgi S, Ueta E, Nanba E, Ito H.

Int Angiol. 2003 Sep;22(3):229-38.

PMID:
14612849

Supplemental Content

Support Center